公司資料
Q32 Bio Inc 股價、新聞與催化劑
- 股票代碼:
- QTTB
- 交易所:
- NASDAQ
- 產業:
- Biopharma
- 所在地:
- United States
股票表現
16.36 USD (+2.44%)
收盤價
最後更新: 2026年8月24日
214M USD
市值
股價為何變動
As of Aug 24, 2026, QTTB closed up 2.44% at $16.36. No new same-company headline was identified in the current news window.
公司概覽
業務概覽
Q32 Bio is a biotechnology company focused on inflammation and immune modulation through complement or related pathways. Its story is built around targeting hard immune-mediated diseases with a specific biological mechanism.
所在地與產業分類
Q32 Bio is headquartered in the United States and listed on NASDAQ. It sits in specialty immunology biotechnology.
商業模式特徵
The company depends on clinical validation, translational progress, and the ability to keep a narrow pipeline funded. Investors usually watch early data and strategic changes.
生技產業定位
Q32 occupies a niche immunology position within biotech. It is catalyst-sensitive because the market needs proof that the pathway can create real clinical differentiation.
未來催化劑
- Q32 Bio's catalysts are bempikibart's alopecia-areata Phase 2 readout, the ongoing SIGNAL-AA / SIGNAL-AD program cadence, and any strategic decision around the complement platform. The company still needs each clinical step to show that the IL-7Rα story is moving from a promising signal into a durable immune-disease franchise.
近期新聞
相似股票
商業成熟度、治療領域或催化劑模式相近的同業公司。